A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Recurrent or Metastatic Cervical Cancer
Clinical trial NCT03676959 · UNKNOWN
Trial details
- NCT number
- NCT03676959
- Sponsor
- Lee's Pharmaceutical Limited
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-16
- Primary completion
- 2022-05-15
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.